Costa Rica's Medtech Shift: From Assembly to Innovation

Jan de Vries · 2026-11-06

Costa Rica isn't just assembling medical devices anymore. It's engineering them. And that shift is starting to turn heads in the global medtech world. For years, the country was known as a manufacturing hub—a place where companies could build devices efficiently and affordably. But now, Costa Rica is betting on a bigger role: becoming a center for engineering, supplier networks, and digital health innovation. It's a move that could reshape how medtech companies think about nearshoring. ### Why Costa Rica Is More Than a Factory Floor Let's be clear: manufacturing still matters. But the real story is what's happening around it. Costa Rica has been quietly building an ecosystem that supports the entire product lifecycle—from concept to customer. That means more engineers, more specialized suppliers, and more digital infrastructure. "We're not just making devices," says one industry insider. "We're solving problems." That mindset is attracting companies that want more than cheap labor. They want partners who can innovate alongside them. ### The Engineering Advantage So what's driving this shift? A few things: - **Talent:** Costa Rica has invested heavily in STEM education, producing a steady stream of engineers and technicians. - **Proximity:** It's a short flight from the U.S., making collaboration easy and supply chains resilient. - **Track record:** Decades of medtech manufacturing have built trust and expertise. But it's not just about having smart people. It's about having them in the right place, with the right support. Costa Rica's free trade zones offer incentives, and the government has been proactive in courting medtech investment. ### The Digital Piece Engineering is one thing. Digital is another. Costa Rica is also pushing into digital health—think software, connectivity, and data. That's where the next wave of medtech value is being created. And the country wants a piece of it. This isn't just talk. Companies are already setting up R&D centers and digital teams. The goal is to move up the value chain, from making parts to designing systems. ### What This Means for U.S. Medtech For U.S. companies, this shift is worth watching. Nearshoring is already popular, but Costa Rica is offering something more: a partner that can handle complex engineering and digital work. That could reduce time-to-market and improve quality. Of course, there are challenges. Scaling engineering talent takes time. Infrastructure needs to keep up. But the direction is clear. Costa Rica is betting that the future of medtech isn't just about where things are made—it's about where they're imagined. And it's putting its chips on the table. ### The Bottom Line Costa Rica's medtech bet is a bet on itself. By expanding beyond manufacturing into engineering and digital, it's positioning itself as a full-service hub. For an industry that's always looking for an edge, that's a compelling proposition. The question is: can it deliver? Early signs say yes.